-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明,無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
LifeStance Health Group, Inc. (NASDAQ:LFST) Receives $8.21 Average Price Target From Analysts
LifeStance Health Group, Inc. (NASDAQ:LFST) Receives $8.21 Average Price Target From Analysts
LifeStance Health Group, Inc. (NASDAQ:LFST – Get Rating) has been assigned an average rating of "Moderate Buy" from the six research firms that are currently covering the company, MarketBeat reports. Two analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 1 year target price among analysts that have covered the stock in the last year is $8.21.
Several brokerages have recently commented on LFST. Cowen lowered their price objective on LifeStance Health Group from $10.00 to $8.00 and set an "outperform" rating on the stock in a research report on Monday, November 14th. Cowen decreased their target price on LifeStance Health Group from $10.00 to $8.00 and set an "outperform" rating on the stock in a research report on Monday, November 14th. Morgan Stanley upgraded LifeStance Health Group from an "equal weight" rating to an "overweight" rating and set a $8.00 target price on the stock in a research report on Friday, January 6th. The Goldman Sachs Group decreased their target price on LifeStance Health Group from $9.00 to $8.00 and set a "neutral" rating on the stock in a research report on Tuesday, November 15th. Finally, Jefferies Financial Group reiterated a "buy" rating and issued a $7.25 target price on shares of LifeStance Health Group in a research report on Monday, November 7th.
Get LifeStance Health Group alerts:LifeStance Health Group Price Performance
Shares of LifeStance Health Group stock opened at $5.24 on Tuesday. The stock's 50-day simple moving average is $5.10 and its 200-day simple moving average is $6.36. LifeStance Health Group has a 52 week low of $4.22 and a 52 week high of $11.25. The company has a market capitalization of $1.97 billion, a price-to-earnings ratio of -6.55 and a beta of 0.61. The company has a quick ratio of 2.25, a current ratio of 2.25 and a debt-to-equity ratio of 0.14.
LifeStance Health Group (NASDAQ:LFST – Get Rating) last announced its quarterly earnings data on Tuesday, November 8th. The company reported ($0.11) EPS for the quarter, beating the consensus estimate of ($0.15) by $0.04. LifeStance Health Group had a negative return on equity of 18.01% and a negative net margin of 33.77%. The business had revenue of $217.56 million for the quarter, compared to the consensus estimate of $219.69 million. As a group, analysts expect that LifeStance Health Group will post -0.6 earnings per share for the current fiscal year.Institutional Investors Weigh In On LifeStance Health Group
Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. OLD National Bancorp IN bought a new position in shares of LifeStance Health Group during the fourth quarter valued at approximately $49,000. Dynamic Advisor Solutions LLC bought a new position in shares of LifeStance Health Group during the fourth quarter valued at approximately $56,000. Ameritas Investment Partners Inc. grew its stake in shares of LifeStance Health Group by 56.6% during the first quarter. Ameritas Investment Partners Inc. now owns 5,575 shares of the company's stock valued at $56,000 after buying an additional 2,016 shares during the last quarter. Point72 Hong Kong Ltd bought a new position in shares of LifeStance Health Group during the second quarter valued at approximately $63,000. Finally, Price T Rowe Associates Inc. MD bought a new position in shares of LifeStance Health Group during the third quarter valued at approximately $75,000. 76.49% of the stock is currently owned by hedge funds and other institutional investors.
About LifeStance Health Group
(Get Rating)
LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.
See Also
- Get a free copy of the StockNews.com research report on LifeStance Health Group (LFST)
- Energizer Holdings Inc; Losing Power Or Electrifying Time To Buy?
- Can Cummins Power To A New High?
- How to Find Penny Stocks to Invest and Trade
- ONSemi Is Marching Higher On Great Results
- What Tyson Foods Q1 Means For Staples Stocks
Receive News & Ratings for LifeStance Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeStance Health Group and related companies with MarketBeat.com's FREE daily email newsletter.
據MarketBeat報道,LifeStance Health Group,Inc.(納斯達克代碼:LFST-GET Rating)目前覆蓋該公司的六家研究公司已將該公司的平均評級定為“中等買入”。兩名分析師對該股的評級為持有建議,四名分析師對該公司發出了買入建議。在過去一年追蹤該股的分析師中,1年目標價的平均水準為8.21美元。
幾家券商最近對LFST發表了評論。考恩在11月14日星期一的一份研究報告中將LifeStance Health Group的目標價從10.00美元下調至8.00美元,並對該股設定了“跑贏大盤”的評級。考恩在11月14日(星期一)的一份研究報告中將LifeStance Health Group的目標價從10.00美元下調至8.00美元,並對該股設定了“跑贏大盤”的評級。摩根士丹利在1月6日(週五)發佈的研究報告中將LifeStance Health Group的評級從持平上調至增持,並為該股設定了8.00美元的目標價。11月15日,週二,高盛夫婦在一份研究報告中將LifeStance Health Group的目標價從9.00美元下調至8.00美元,並將該股的評級定為中性。最後,傑富瑞金融集團在11月7日週一發佈的研究報告中重申了買入評級,並對LifeStance Health Group的股票發佈了7.25美元的目標價。
到達LifeStance健康集團警報:LifeStance Health Group價格表現
週二,LifeStance Health Group的股票開盤報5.24美元。該股的50日簡單移動均線切入位為5.10美元,200日簡單移動均線切入位為6.36美元。LifeStance Health Group的52周低點為4.22美元,52周高點為11.25美元。該公司市值19.7億美元,本益比為-6.55,貝塔係數為0.61。該公司的速動比率為2.25,流動比率為2.25,債務權益比為0.14。
LifeStance Health Group(納斯達克:LFST-GET評級)最近一次公佈季度收益數據是在11月8日(星期二)。該公司公佈了本季度每股收益(0.11美元),比普遍預期的(0.15美元)高出0.04美元。LifeStance Health Group的淨資產回報率為負18.01%,淨利潤率為負33.77%。該業務本季度的收入為2.1756億美元,而普遍預期為2.1969億美元。分析師預計,作為一個整體,LifeStance Health Group本財年的每股收益將為0.6美元。機構投資者看好LifeStance Health Group
對沖基金和其他機構投資者最近增持或減持了該股。Old National Bancorp IN在第四季度購買了LifeStance Health Group的新股票頭寸,價值約49,000美元。Dynamic Advisor Solutions LLC在第四季度購買了LifeStance Health Group的新股票頭寸,價值約56,000美元。今年第一季度,ameritas Investment Partners Inc.在LifeStance Health Group的持股增加了56.6%。Ameritas Investment Partners Inc.現在持有該公司5,575股股票,價值56,000美元,該公司在上個季度又購買了2,016股股票。Point72 Hong Kong Ltd在第二季度購買了LifeStance Health Group的新股票頭寸,價值約63,000美元。最後,Price T Rowe Associates Inc.MD在第三季度購買了LifeStance Health Group價值約7.5萬美元的新股票頭寸。76.49%的股票目前由對沖基金和其他機構投資者持有。
關於LifeStance Health Group
(獲取評級)
LifeStance Health Group,Inc.通過其子公司提供門診精神健康服務。該公司為患者提供一整套精神健康服務,包括精神評估和治療、心理和神經心理測試,以及個人、家庭和團體治療。
另請參閱
- 免費獲取StockNews.com關於LifeStance Health Group(LFST)的研究報告
- 勁量控股公司;失去電力或使購買時間帶電?
- 康明斯能再創新高嗎?
- 如何找到可以投資和交易的細價股
- ONSemi以優異的業績走得更高
- 泰森食品第一季度對史泰博股票意味著什麼
接受LifeStance健康集團日報的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收LifeStance Health Group和相關公司的最新新聞和分析師評級的每日摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國,moomoo上的投資產品和服務由Moomoo Financial Inc.提供,一家受美國證券交易委員會(SEC)監管的持牌主體。 Moomoo Financial Inc.是金融業監管局(FINRA)和證券投資者保護公司(SIPC)的成員。
在新加坡,moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供,該公司受新加坡金融管理局(MAS)監管(牌照號碼︰CMS101000) ,持有資本市場服務牌照 (CMS) ,持有財務顧問豁免(Exempt Financial Adviser)資質。本內容未經新加坡金融管理局的審查。
在澳大利亞,moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供,該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構(AFSL No. 224663)。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件,這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大,透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供,並受加拿大投資監管機構(CIRO)監管。
在馬來西亞,moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供,該公司受馬來西亞證券監督委員會(SC)監管(牌照號碼︰eCMSL/A0397/2024) ,持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.,Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能,分享給你的好友吧